CLASS II ONGOING Device recall · Reported 17 Jun 2026 · FDA Enforcement Report

Exent Analyser recalled by The Binding Site Group

The Binding Site Group is recalling Exent Analyser, distributed nationwide in the US. The recall was initiated on 16 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Model No; IE800A; EXENT Analyser; UDI; 05051700020886, Serial Number; 101150, Software version; v1.0.20.
Quantity recalled1

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2362-2026
FDA event ID
98830
Recalling firm
The Binding Site Group, Birmingham, N/A
Classification
Class II
Status
Ongoing
Recall initiated
16 Apr 2026
FDA classified
9 Jun 2026
Reported
17 Jun 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

16 Apr 2026Recall initiated by company
9 Jun 2026Classified by FDA+54 days
17 Jun 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was reported that plates 2 and 3 were marked as passed , although it appeared that QC had not been performed on these plates, despite samples being measured. The potential clinical hazards include false or missed detection of M-protein (false positive); and falsely elevated or decreased M-protein concentration.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Brand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20 Product Description: The EXENT Analyser is an automated analyser intended for the qualitative and quantitative in vitro measurement of analytes in human body fluids used in conjunction with the EXENT assays.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Is Exent Analyser recalled?

Yes. The Binding Site Group recalled Exent Analyser on 16 Apr 2026. The recall is Class II and its status is Ongoing. Recall number Z-2362-2026.

Why was it recalled?

It was reported that plates 2 and 3 were marked as passed , although it appeared that QC had not been performed on these plates, despite samples being measured. The potential clinical hazards include false or missed detection of M-protein (false positive); and falsely elevated or decreased M-protein concentration.

Which lots are affected?

Lot Code: Model No; IE800A; EXENT Analyser; UDI; 05051700020886, Serial Number; 101150, Software version; v1.0.20.

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Test Kits & Diagnostics recalls

All 2,656